More than 50 years of landmark results
Since 1967, Lowey Dannenberg has represented investors and major corporations in complex litigation, recovering billions of dollars on their behalf.Solutions for Complex Cases
Professional Recommendations
Recent Cases
Shelled Eggs
Antitrust, Commodities
On June 8, Lowey Dannenberg Chairman Vincent Briganti was appointed as Co-Lead Counsel for the Direct Purchaser Plaintiffs in In Re: Shell Eggs Antitrust Litigation, No. 3:26-md-03175-JDP (W.D. Wisc.) Plaintiffs […]
Amitza
Healthcare
Lowey Dannenberg, on behalf of named plaintiff Premera Blue Cross, is leading a class on behalf of Third-Party Payers of Amitiza (Lubiprostone) against Takeda Pharmaceutical Company Ltd. and related entities. […]
Amgen
Health Care, Healthcare
On September 30, 2025, the U.S. District Court for the Eastern District of Virginia largely denied Amgen’s motion to dismiss in CareFirst of Maryland Inc. et al. v. Amgen Inc. […]
News
Lowey Dannenberg Defeats Yodlee’s Motion to Dismiss in FinTech Data Privacy Case
On February 15, 2021, Magistrate Judge Sallie Kim of the U.S. District Court for the Northern District of California granted-in-part and denied-in-part Defendants Yodlee, Inc.’s and Envestnet Inc.’s motions to dismiss under Federal Rule of Civil Procedure 12(b)(6) and...
Blog
AECPA’s Failure to Address Monopolists’ Abuse of Arbitration Is Bad For Everyone
Last month I had the opportunity to help organize a CLE webinar with the New York State Bar Association on the topic of a new Senate legislation, the Anticompetitive Exclusionary Conduct Prevention Act (AECPA). The discussion was led by leading antitrust academics and practitioners: Seton Hall...